Yahoo
OTC Markets OTCPK - Delayed Quote USD

ENvue Medical, Inc. (FEED)

0.2220 +0.0020 (+0.91%)
At close: October 30 at 4:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
1,926
2,553
2,558
2,283
752
Cost of Revenue
2,428
2,400
1,050
746
585
Gross Profit
-502
153
1,508
1,537
167
Operating Expense
14,590
11,888
5,090
4,973
5,179
Operating Income
-15,092
-11,735
-3,582
-3,436
-5,012
Net Non Operating Interest Income Expense
4,830
4,397
-104
-246
-401
Other Income Expense
--
-11,154
--
--
--
Pretax Income
-21,416
-18,492
-3,686
-3,682
-5,413
Tax Provision
-353
-307
19
29
35
Net Income Common Stockholders
-49,188
-16,775
-3,705
-3,711
-5,448
Diluted NI Available to Com Stockholders
-49,188
-16,775
-3,705
-3,711
-5,448
Basic EPS
-302.64
-320.28
-1.65k
-2.80k
-5.07k
Diluted EPS
-302.64
-320.28
-1.65k
-2.80k
-5.07k
Basic Average Shares
237.7600
52.3770
2.2480
1.3250
1.0750
Diluted Average Shares
237.7600
52.3770
2.2480
1.3250
1.0750
Total Operating Income as Reported
-26,246
-22,889
-3,582
-3,436
-5,012
Total Expenses
17,018
14,288
6,140
5,719
5,764
Net Income from Continuing & Discontinued Operation
-21,063
-18,185
-3,705
-3,711
-5,448
Normalized Income
-10,092.8514
-7,216.1564
-3,705
-3,711
-5,448
Interest Expense
--
--
135
135
347
Net Interest Income
4,830
4,397
-104
-246
-401
EBIT
-14,790
-11,735
-3,582
-3,547
-5,066
EBITDA
-13,839
-10,838
-3,581
-3,546
-5,065
Reconciled Cost of Revenue
2,428
2,400
1,050
746
585
Reconciled Depreciation
951
897
1
1
1
Net Income from Continuing Operation Net Minority Interest
-21,063
-18,185
-3,705
-3,711
-5,448
Total Unusual Items Excluding Goodwill
-11,154
-11,154
0
--
0
Total Unusual Items
-11,154
-11,154
0
--
0
Normalized EBITDA
-2,685
316
-3,581
-3,546
-5,065
Tax Rate for Calcs
0
0
0.0003
0
0.0003
Tax Effect of Unusual Items
-183.8514
-185.1564
0
0
0
12/31/2022 - 5/28/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: